tolvaptan has been researched along with Abnormality, Heart in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Kanai, A; Kobayashi, T; Kojima, T; Sumitomo, N; Yoshiba, S | 1 |
Fujii, T; Katayama, Y; Masuhara, H; Ozawa, T; Shiono, N; Watanabe, Y | 1 |
Busovsky-McNeal, M; Chakravarti, S | 1 |
3 other study(ies) available for tolvaptan and Abnormality, Heart
Article | Year |
---|---|
Efficacy and safety of tolvaptan after pediatric congenital heart disease surgery.
Topics: Antidiuretic Hormone Receptor Antagonists; Body Weight; Cardiac Surgical Procedures; Female; Heart Defects, Congenital; Humans; Infant; Male; Postoperative Complications; Retrospective Studies; Tolvaptan; Treatment Outcome | 2021 |
Safety and effectiveness of tolvaptan for fluid management after pediatric cardiovascular surgery.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardiac Surgical Procedures; Child; Child, Preschool; Female; Follow-Up Studies; Heart Defects, Congenital; Hemodynamics; Humans; Infant; Kidney; Male; Postoperative Care; Retrospective Studies; Tolvaptan; Treatment Outcome; Urodynamics | 2017 |
Use of Tolvaptan in a Patient With Palliated Congenital Heart Disease.
Topics: Adolescent; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Heart Defects, Congenital; Humans; Male; Tolvaptan | 2018 |